H3 K27M-Altered Diffuse Midline Gliomas: A Review

H3 K27M-Altered Diffuse Midline Gliomas: A Review

Diffuse midline glioma H3 K27M-altered is a recently renamed high-grade glioma in the 2021 World Health Organization (WHO) Classification of Central Nervous System Tumors, previously being labelled diffuse midline glioma H3 K27M-mutant in the 2016 update and diffuse intrinsic pontine glioma prior to...

Full description

Bibliographic Details
Main Authors:	Karol Wiśniewski, Andrew Ghaly, Kate Drummond, Andreas Fahlstrӧm
Format:	Article
Language:	English
Published:	Thieme Medical Publishers, Inc. 2023-08-01
Series:	Indian Journal of Neurosurgery
Subjects:	diffuse midline glioma H3.1 or H3.2 K27-mutant H3-wildtype with EZHIP overexpression EGFR-mutant H3.3 K27-mutant
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1771192

Similar Items

Diffuse midline glioma, H3-K27M mutant: Awareness leads to identification
by: Sadhana Tiwari, et al.
Published: (2019-01-01)

Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
by: Yu-An Li, et al.
Published: (2024-06-01)

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
by: Rouzbeh Banan, et al.
Published: (2017-12-01)

K27M-mutant histone-3 as a novel target for glioma immunotherapy
by: Katharina Ochs, et al.
Published: (2017-07-01)

New progress in the treatment of diffuse midline glioma with H3K27M alteration
by: Zhi Yang, et al.
Published: (2024-01-01)

Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas
by: Jotaro On, et al.
Published: (2021-04-01)

H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions
by: Leo F. Nonnenbroich, et al.
Published: (2024-06-01)

Single-cell RNA sequencing of anaplastic ependymoma and H3K27M-mutant diffuse midline glioma
by: Dongdong Zang, et al.
Published: (2024-02-01)

H3 K27-altered diffuse midline glioma in adults arising from atypical regions: Two case reports and literature review
by: Narushi Sugii, MD, PhD, et al.
Published: (2024-01-01)

H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant
by: Sachi Maeda, et al.
Published: (2020-02-01)

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
by: Ji-ping Zhao, et al.
Published: (2022-12-01)

Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review
by: Arian Lasocki, et al.
Published: (2022-11-01)

Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas
by: Huy Gia Vuong, et al.
Published: (2022-03-01)

Chromatin mutations in pediatric high grade gliomas
by: Hsiao P. J. Voon, et al.
Published: (2023-01-01)

Multi-omics approaches reveal that diffuse midline gliomas present altered DNA replication and are susceptible to replication stress therapy
by: Anastasia E. Hains, et al.
Published: (2024-12-01)

Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker
by: Prachi Agarwal, et al.
Published: (2021-01-01)

Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman
by: Justin Thomas Low, et al.
Published: (2021-06-01)

Histone-mutant glioma presenting as diffuse leptomeningeal disease
by: Tanvi Nadkarni, et al.
Published: (2021-09-01)

Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas, H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location
by: David Castel, et al.
Published: (2018-11-01)

Clinico–Pathological Features of Diffuse Midline Glioma, H3 K27-Altered in Adults: A Comprehensive Review of the Literature with an Additional Single-Institution Case Series
by: Giuseppe Broggi, et al.
Published: (2024-11-01)

The diverse landscape of histone-mutant pediatric high-grade gliomas: A narrative review
by: Evan Lubanszky, et al.
Published: (2022-01-01)

The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models
by: Liam M. Furst, et al.
Published: (2024-06-01)

A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis
by: A. Kaywan Aftahy, et al.
Published: (2023-02-01)

Imaging findings of diffuse midline glioma with H3K27M mutation in the dorsal medulla oblongata: A rare case report
by: MingKang Shan, et al.
Published: (2023-12-01)

Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma
by: Gabrielle Price, et al.
Published: (2021-07-01)

Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
by: Erik R. Peterson, et al.
Published: (2024-04-01)

Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study
by: Federica Garibotto, et al.
Published: (2020-06-01)

H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes
by: Charles A. Day, et al.
Published: (2022-10-01)

DNA Methylation Profiles Are Stable in H3 K27M-Mutant Diffuse Midline Glioma Neurosphere Cell Lines
by: Matthew J. Schniederjan, et al.
Published: (2024-04-01)

Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review
by: Lucia De Martino, et al.
Published: (2023-07-01)

Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells
by: Tiantian Zhang, et al.
Published: (2020-02-01)

Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas
by: Aleeha Noon, et al.
Published: (2023-06-01)

Tumor-Associated Microenvironment of Adult Gliomas: A Review
by: Vincenzo Di Nunno, et al.
Published: (2022-07-01)

Diagnostic and therapeutical approaches to H3K27M-altered diffuse midline glioma in children: a review
by: D. A. Morgacheva, et al.
Published: (2023-12-01)

Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma
by: Monika Sharma, et al.
Published: (2023-10-01)

Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient
by: Ran Cheng, et al.
Published: (2021-06-01)

Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort
by: Nobuhide Hayashi, et al.
Published: (2024-07-01)

Deep learning‐based prediction of H3K27M alteration in diffuse midline gliomas based on whole‐brain MRI
by: Bowen Huang, et al.
Published: (2023-08-01)

The immune response behind peptide vaccination in diffuse midline glioma
by: Craig A. Vincent, et al.
Published: (2024-08-01)

Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration
by: Bowen Huang, et al.
Published: (2023-10-01)